VEGFR-TKIs combined with chemotherapy for advanced non-small cell lung cancer: A systematic review

Introduction: To estimate the efficacy and safety of vascular endothelial growth factor receptor tyrosine kinase inhibitors (VEGFR-TKIs) in combination with chemotherapy for patients with advanced non-small cell lung cancer (NSCLC). Methods: We searched PubMed, PMC database, EMBASE, EBSCO-Medline, C...

Descripción completa

Detalles Bibliográficos
Autores principales: Liu, Lian, Zhang, Yue, Wei, Jia, Chen, Zhaoxin, Yu, Jing
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Ivyspring International Publisher 2019
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6400799/
https://www.ncbi.nlm.nih.gov/pubmed/30854085
http://dx.doi.org/10.7150/jca.29643

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6400799/
https://www.ncbi.nlm.nih.gov/pubmed/30854085
http://dx.doi.org/10.7150/jca.29643

Ejemplares similares